Literature DB >> 14758871

The epidemiology of diabetes in a large Israeli HMO.

Gabriel Chodick1, Anthony D Heymann, Varda Shalev, Ehud Kookia.   

Abstract

Diabetes is one of the most prevalent non-communicable disease globally and it is one of the leading cause for death in most developed countries. The current population-based study aim was to describe to the epidemiology of diabetes in Israel by using our HMO's automated medical databases. All diabetic patients appearing in the diabetes registry among 1.6 million insured members in the second largest HMO in Israel were selected for epidemiological analysis. We identified 39,768 diabetic patients (crude prevalence rate of 2.6%). Higher age-specific prevalence rates were recorded among males. The highest age-specific prevalence rate of diabetes was calculated for men aged 75 and above (18.1%). A rise in the prevalence and mortality rates was recorded between 1999 and 2001 female (from 1.9 to 2.8 per 100,000) and for men (from 2.3 to 3.8 per 100,000). The current study demonstrates the potential of using large automated medical and administrative databases to determine the epidemiology of chronic disease, such as diabetes. The rise in the prevalence and mortality of diabetes patients has important implication for Israeli health authorities and should be seriously regarded.

Entities:  

Mesh:

Year:  2003        PMID: 14758871     DOI: 10.1023/b:ejep.0000006635.36802.c8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  43 in total

1.  The Israel Diabetes and Cognitive Decline (IDCD) study: Design and baseline characteristics.

Authors:  Michal Schnaider Beeri; Ramit Ravona-Springer; Erin Moshier; James Schmeidler; James Godbold; Tomas Karpati; Derek Leroith; Keren Koifman; Efrat Kravitz; Rachel Price; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann
Journal:  Alzheimers Dement       Date:  2014-08-20       Impact factor: 21.566

2.  Epidemiology and comorbidity of severe mental illnesses in the community: findings from a computerized mental health registry in a large Israeli health organization.

Authors:  Arad Kodesh; Inbal Goldshtein; Marc Gelkopf; Iris Goren; Gabriel Chodick; Varda Shalev
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-02-07       Impact factor: 4.328

3.  Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab.

Authors:  Omer Gendelman; Dahlia Weitzman; Vered Rosenberg; Varda Shalev; Gabriel Chodick; Howard Amital
Journal:  Br J Clin Pharmacol       Date:  2018-01-25       Impact factor: 4.335

4.  The association between adherence to cardiovascular medications and healthcare utilization.

Authors:  Tzahit Simon-Tuval; Noa Triki; Gabriel Chodick; Dan Greenberg
Journal:  Eur J Health Econ       Date:  2015-06-16

5.  Advanced-Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide Database.

Authors:  Yael Barer; Tanya Gurevich; Gabriel Chodick; Nir Giladi; Ruth Gross; Raanan Cohen; Lars Bergmann; Yash J Jalundhwala; Varda Shalev; Meital Grabarnik-John; Avner Thaler
Journal:  Mov Disord Clin Pract       Date:  2022-04-29

6.  Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine.

Authors:  Tal Patalon; Sivan Gazit; Virginia E Pitzer; Ottavia Prunas; Joshua L Warren; Daniel M Weinberger
Journal:  JAMA Intern Med       Date:  2022-02-01       Impact factor: 44.409

7.  Trends in statin therapy initiation during the period 2000-2010 in Israel.

Authors:  Varda Shalev; Clara Weil; Raanan Raz; Inbal Goldshtein; Dahlia Weitzman; Gabriel Chodick
Journal:  Eur J Clin Pharmacol       Date:  2014-01-25       Impact factor: 2.953

8.  Persistence with statins and onset of rheumatoid arthritis: a population-based cohort study.

Authors:  Gabriel Chodick; Howard Amital; Yoav Shalem; Ehud Kokia; Anthony D Heymann; Avi Porath; Varda Shalev
Journal:  PLoS Med       Date:  2010-09-07       Impact factor: 11.069

9.  Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.

Authors:  Carolyn S P Lam; Avraham Karasik; Cheli Melzer-Cohen; Matthew A Cavender; Shun Kohsaka; Anna Norhammar; Marcus Thuresson; Hungta Chen; Eric Wittbrodt; Peter Fenici; Mikhail Kosiborod
Journal:  Diabetes Obes Metab       Date:  2021-03-23       Impact factor: 6.577

10.  Disparities in diabetes care: role of the patient's socio-demographic characteristics.

Authors:  Rachel Wilf-Miron; Ronit Peled; Einat Yaari; Orna Shem-Tov; Vainer Anna Weinner; Avi Porath; Ehud Kokia
Journal:  BMC Public Health       Date:  2010-11-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.